Rockland Trust Co. Grows Holdings in Zoetis Inc. $ZTS

Rockland Trust Co. raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 2,055.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 148,557 shares of the company’s stock after purchasing an additional 141,664 shares during the quarter. Rockland Trust Co.’s holdings in Zoetis were worth $18,691,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. CIBC Asset Management Inc lifted its holdings in shares of Zoetis by 4.3% in the 3rd quarter. CIBC Asset Management Inc now owns 251,495 shares of the company’s stock worth $36,745,000 after buying an additional 10,434 shares during the period. Mitsubishi UFJ Trust & Banking Corp increased its stake in shares of Zoetis by 6.5% during the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 295,482 shares of the company’s stock valued at $43,235,000 after buying an additional 18,040 shares during the period. Ninety One UK Ltd raised its holdings in shares of Zoetis by 19.6% in the third quarter. Ninety One UK Ltd now owns 1,119,132 shares of the company’s stock valued at $163,751,000 after acquiring an additional 183,686 shares in the last quarter. Quilter Plc raised its holdings in shares of Zoetis by 10.2% in the third quarter. Quilter Plc now owns 438,959 shares of the company’s stock valued at $64,228,000 after acquiring an additional 40,615 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in Zoetis by 79.2% in the fourth quarter. Nordea Investment Management AB now owns 4,932,787 shares of the company’s stock worth $622,222,000 after acquiring an additional 2,179,578 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ZTS has been the topic of several recent research reports. The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a report on Monday, December 15th. HSBC set a $140.00 price target on shares of Zoetis in a report on Wednesday, December 10th. Leerink Partners reiterated a “market perform” rating on shares of Zoetis in a research note on Tuesday, March 10th. UBS Group set a $136.00 price objective on shares of Zoetis in a report on Thursday, January 29th. Finally, Piper Sandler reissued a “neutral” rating and issued a $135.00 price objective (down from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Six research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Zoetis currently has a consensus rating of “Hold” and an average price target of $152.91.

Zoetis Price Performance

Shares of ZTS stock opened at $118.02 on Wednesday. The stock’s 50-day moving average is $123.12 and its 200 day moving average is $128.57. Zoetis Inc. has a 1-year low of $113.29 and a 1-year high of $172.23. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. The company has a market cap of $49.82 billion, a P/E ratio of 19.60, a PEG ratio of 1.78 and a beta of 0.95.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. The business had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The firm’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Monday, April 20th. Zoetis’s payout ratio is 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.